FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385320440> ?p ?o ?g. }

• W4385320440 endingPage "103484" @default.
• W4385320440 startingPage "103484" @default.
• W4385320440 abstract "In preclinical research, the use of [18F]Fluorodesoxyglucose (FDG) as a biomarker for neurodegeneration may induce bias due to enhanced glucose uptake by immune cells. In this study, we sought to investigate synaptic vesicle glycoprotein 2A (SV2A) PET with [18F]UCB-H as an alternative preclinical biomarker for neurodegenerative processes in two mouse models representing the pathological hallmarks of Alzheimer's disease (AD).A total of 29 PS2APP, 20 P301S and 12 wild-type mice aged 4.4 to 19.8 months received a dynamic [18F]UCB-H SV2A-PET scan (14.7 ± 1.5 MBq) 0-60 min post injection. Quantification of tracer uptake in cortical, cerebellar and brainstem target regions was implemented by calculating relative volumes of distribution (VT) from an image-derived-input-function (IDIF). [18F]UCB-H binding was compared across all target regions between transgenic and wild-type mice. Additional static scans were performed in a subset of mice to compare [18F]FDG and [18F]GE180 (18 kDa translocator protein tracer as a surrogate for microglial activation) standardized uptake values (SUV) with [18F]UCB-H binding at different ages. Following the final scan, a subset of mouse brains was immunohistochemically stained with synaptic markers for gold standard validation of the PET results.[18F]UCB-H binding in all target regions was significantly reduced in 8-months old P301S transgenic mice when compared to wild-type controls (temporal lobe: p = 0.014; cerebellum: p = 0.0018; brainstem: p = 0.0014). Significantly lower SV2A tracer uptake was also observed in 13-months (temporal lobe: p = 0.0080; cerebellum: p = 0.006) and 19-months old (temporal lobe: p = 0.0042; cerebellum: p = 0.011) PS2APP transgenic versus wild-type mice, whereas the brainstem revealed no significantly altered [18F]UCB-H binding. Immunohistochemical analyses of post-mortem mouse brain tissue confirmed the SV2A PET findings. Correlational analyses of [18F]UCB-H and [18F]FDG using Pearson's correlation coefficient revealed a significant negative association in the PS2APP mouse model (R = -0.26, p = 0.018). Exploratory analyses further stressed microglial activation as a potential reason for this inverse relationship, since [18F]FDG and [18F]GE180 quantification were positively correlated in this cohort (R = 0.36, p = 0.0076).[18F]UCB-H reliably depicts progressive synaptic loss in PS2APP and P301S transgenic mice, potentially qualifying as a more reliable alternative to [18F]FDG as a biomarker for assessment of neurodegeneration in preclinical research." @default.
• W4385320440 created "2023-07-28" @default.
• W4385320440 creator A5003902715 @default.
• W4385320440 creator A5006533926 @default.
• W4385320440 creator A5018864246 @default.
• W4385320440 creator A5022060492 @default.
• W4385320440 creator A5024397817 @default.
• W4385320440 creator A5027420105 @default.
• W4385320440 creator A5037412930 @default.
• W4385320440 creator A5047813770 @default.
• W4385320440 creator A5049286444 @default.
• W4385320440 creator A5049725109 @default.
• W4385320440 creator A5061711507 @default.
• W4385320440 creator A5069184646 @default.
• W4385320440 creator A5070475227 @default.
• W4385320440 creator A5074411763 @default.
• W4385320440 creator A5078849938 @default.
• W4385320440 creator A5080983368 @default.
• W4385320440 creator A5084033552 @default.
• W4385320440 creator A5084766900 @default.
• W4385320440 creator A5090357263 @default.
• W4385320440 date "2023-01-01" @default.
• W4385320440 modified "2023-10-17" @default.
• W4385320440 title "Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging" @default.
• W4385320440 cites W1968276382 @default.
• W4385320440 cites W1993465897 @default.
• W4385320440 cites W2013815976 @default.
• W4385320440 cites W2053116497 @default.
• W4385320440 cites W2056313099 @default.
• W4385320440 cites W2057249855 @default.
• W4385320440 cites W2060851420 @default.
• W4385320440 cites W2063017390 @default.
• W4385320440 cites W2064358322 @default.
• W4385320440 cites W2070711680 @default.
• W4385320440 cites W2098655420 @default.
• W4385320440 cites W2135661040 @default.
• W4385320440 cites W2162807572 @default.
• W4385320440 cites W2167840686 @default.
• W4385320440 cites W2204761283 @default.
• W4385320440 cites W2276615166 @default.
• W4385320440 cites W2311377444 @default.
• W4385320440 cites W2315782369 @default.
• W4385320440 cites W2341208655 @default.
• W4385320440 cites W2581215498 @default.
• W4385320440 cites W2786084903 @default.
• W4385320440 cites W2798054687 @default.
• W4385320440 cites W2883737562 @default.
• W4385320440 cites W2901231775 @default.
• W4385320440 cites W2939408745 @default.
• W4385320440 cites W2943930324 @default.
• W4385320440 cites W2976163884 @default.
• W4385320440 cites W3025287530 @default.
• W4385320440 cites W3111509171 @default.
• W4385320440 cites W3123070629 @default.
• W4385320440 cites W3175579540 @default.
• W4385320440 cites W3197163835 @default.
• W4385320440 cites W3205542324 @default.
• W4385320440 cites W3206625567 @default.
• W4385320440 cites W4210754619 @default.
• W4385320440 cites W4220661253 @default.
• W4385320440 cites W4285742735 @default.
• W4385320440 cites W4292112624 @default.
• W4385320440 cites W90630876 @default.
• W4385320440 doi "https://doi.org/10.1016/j.nicl.2023.103484" @default.
• W4385320440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37541098" @default.
• W4385320440 hasPublicationYear "2023" @default.
• W4385320440 type Work @default.
• W4385320440 citedByCount "0" @default.
• W4385320440 crossrefType "journal-article" @default.
• W4385320440 hasAuthorship W4385320440A5003902715 @default.
• W4385320440 hasAuthorship W4385320440A5006533926 @default.
• W4385320440 hasAuthorship W4385320440A5018864246 @default.
• W4385320440 hasAuthorship W4385320440A5022060492 @default.
• W4385320440 hasAuthorship W4385320440A5024397817 @default.
• W4385320440 hasAuthorship W4385320440A5027420105 @default.
• W4385320440 hasAuthorship W4385320440A5037412930 @default.
• W4385320440 hasAuthorship W4385320440A5047813770 @default.
• W4385320440 hasAuthorship W4385320440A5049286444 @default.
• W4385320440 hasAuthorship W4385320440A5049725109 @default.
• W4385320440 hasAuthorship W4385320440A5061711507 @default.
• W4385320440 hasAuthorship W4385320440A5069184646 @default.
• W4385320440 hasAuthorship W4385320440A5070475227 @default.
• W4385320440 hasAuthorship W4385320440A5074411763 @default.
• W4385320440 hasAuthorship W4385320440A5078849938 @default.
• W4385320440 hasAuthorship W4385320440A5080983368 @default.
• W4385320440 hasAuthorship W4385320440A5084033552 @default.
• W4385320440 hasAuthorship W4385320440A5084766900 @default.
• W4385320440 hasAuthorship W4385320440A5090357263 @default.
• W4385320440 hasBestOaLocation W43853204401 @default.
• W4385320440 hasConcept C102230213 @default.
• W4385320440 hasConcept C104317684 @default.
• W4385320440 hasConcept C141035611 @default.
• W4385320440 hasConcept C142724271 @default.
• W4385320440 hasConcept C169760540 @default.
• W4385320440 hasConcept C185592680 @default.
• W4385320440 hasConcept C199374082 @default.
• W4385320440 hasConcept C2775842073 @default.
• W4385320440 hasConcept C2776791281 @default.

• next